2nd Quarter - Report

AMERICAN CLINICAL LABORATORY ASSN for AMERICAN CLINICAL LABORATORY ASSN

Firm
Client
Income
—
Expenses
$187,432
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

Health reform law implementation including application of medical device tax to laboratory tests; discussion and possible legislation regarding FDA oversight of laboratory developed tests; the Centers for Medicare and Mediciad Services physician signature issue; deficit reduction legislation including a uniform coinsurance or a copayment for laboratory tests in Medicare; in-office ancillary services including pathology.

LobbyistCovered position, as disclosed
JASON DUBOIS Vice President, Government Affairs
JO ANNE GLISSON Senior Vice President
ALAN MERTZ President
DAVID ALAN MONGILLO Vice President, Policy and Medical Affairs
FRANCESCA FIERRO O'REILLY New Vice President, Government Affairs

Contacted: Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.